We are live on ! Find out more
ACRS icon

Aclaris Therapeutics
ACRS

82 hedge funds and large institutions have $198M invested in Aclaris Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,181% more call options, than puts

Call options by funds: $3.08M | Put options by funds: $240K

357% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 7

205% more capital invested

Capital invested by funds: $65M → $198M (+$133M)

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

44% more funds holding

Funds holding: 57 → 82 (+25)

14.59% more ownership

Funds ownership: 59.82% → 74.4% (+15%)

32% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 22

Holders
82
Holders Change
+25
Holders Change %
+43.86%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
32
Increased
15
Reduced
22
Closed
7
Calls
$3.08M
Puts
$240K
Net Calls
+$2.83M
Net Calls Change
+$2.77M

Top Buyers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
+$8.25M
2
FCMI
Foresite Capital Management III
California
+$3.95M
3
FCMI
Foresite Capital Management IV
California
+$3.4M
4
GTC
Ghost Tree Capital
New York
+$2.74M
5
RSCM
Rock Springs Capital Management
Maryland
+$2.53M

Top Sellers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
-$3.34M
2
JGC
J. Goldman & Co
New York
-$1.48M
3
ECM
Endurant Capital Management
California
-$1.29M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.05M
5
TI
Telemetry Investments
New York
-$931K
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Sphera Funds Management
Israel
$971K +$633K +150,000 New
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$880K +$587K +139,229 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$715K +$466K +110,549 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$677K -$19.4K -4,594 -4%
Verition Fund Management
30
Verition Fund Management
Connecticut
$640K +$417K +98,845 New
Invesco
31
Invesco
Georgia
$605K -$17.1K -4,044 -4%
Northern Trust
32
Northern Trust
Illinois
$586K -$21.5K -5,095 -5%
Two Sigma Investments
33
Two Sigma Investments
New York
$557K +$363K +86,092 New
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$551K -$459K -108,834 -56%
State Street
35
State Street
Massachusetts
$505K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$425K – – –
Capstone Investment Advisors
37
Capstone Investment Advisors
New York
$398K +$260K +61,534 New
HighTower Advisors
38
HighTower Advisors
Illinois
$373K -$9.22K -2,185 -4%
BFM
39
Boothbay Fund Management
New York
$333K +$217K +51,461 New
PVI
40
Pura Vida Investments
New York
$324K +$211K +50,000 New
Group One Trading
41
Group One Trading
Illinois
$308K +$169K +40,033 +527%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$305K +$101K +24,000 +103%
TI
43
Telemetry Investments
New York
$303K -$931K -220,666 -83%
6CM
44
683 Capital Management
New York
$299K +$195K +46,168 New
JGC
45
J. Goldman & Co
New York
$292K -$1.48M -351,424 -89%
Cambridge Investment Research Advisors
46
Cambridge Investment Research Advisors
Iowa
$290K +$308 +73 +0.2%
Citigroup
47
Citigroup
New York
$275K +$179K +42,475 New
Citadel Advisors
48
Citadel Advisors
Florida
$267K +$68.5K +16,238 +65%
Wells Fargo
49
Wells Fargo
California
$213K +$134K +31,719 +2,606%
QSS
50
Quantitative Systematic Strategies
Florida
$193K +$126K +29,847 New
1
2
3 4

ACRS Hedge Fund Activity: Q4 2020 in Review

82 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Aclaris Therapeutics (ACRS) for Q4 2020, worth a combined $198M — up 205% from $65M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ACRS positions and 7 closed out — a net gain of 25 holders — while 15 added to existing stakes and 22 trimmed.

The largest buyer was VR Adviser, opening a new position worth an estimated $8.25M. The largest seller was Samsara BioCapital, cutting an estimated $3.34M.

  • 82 institutional investors held Aclaris Therapeutics (ACRS) as of Q4 2020, up from 57 in Q3 2020.
  • Funds reported $198M of Aclaris Therapeutics stock for Q4 2020, up 205% quarter-over-quarter.
  • 32 funds opened new Aclaris Therapeutics positions in Q4 2020 and 7 closed out, a net change of +25 holders.
  • The largest Aclaris Therapeutics buyer in Q4 2020 was VR Adviser, an estimated $8.25M added.
  • The largest Aclaris Therapeutics seller in Q4 2020 was Samsara BioCapital, an estimated $3.34M sold.

Based on aggregated 13F filings for Q4 2020.